Tag - daiichi-sankyo

 
Menu
Search
 
August 15, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

DAIICHI SANKYO

Health minister Keizo Takemi fields questions from reporters in March after a Cabinet meeting to deal with health problems caused by Kobayashi Pharmaceutical's beni kōji red yeast rice supplements.
JAPAN / Science & Health
Aug 14, 2024
Health Minister Keizo Takemi on how to improve Japan's health care system
Digitalization, hiring high-skilled foreign workers and increasing wages are among the steps that Japan could take.
In the past 11 months, health minister Keizo Takemi has been charting his own path, seeking to make Japan's health care policies more global and digitalized.
JAPAN / Science & Health
Aug 14, 2024
Global mindset crucial for reform of Japan's health care, minister says
International strategies and domestic health care reform are inextricably linked, says health minister Keizo Takemi.
Prime Minister Fumio Kishida receives a COVID-19 booster shot in Tokyo on Nov. 11.
JAPAN / Science & Health
Nov 28, 2023
Japan approves first domestically developed COVID-19 XBB vaccine
The XBB-adapted coronavirus vaccine will be available as a booster under the nation’s free COVID-19 vaccination program beginning next week.
Daiichi Sankyo is aiming for at least ¥900 billion of revenue from its oncology business in the fiscal year ending in March 2026.
BUSINESS
Oct 20, 2023
Merck signs $5.5 billion deal with Daiichi for cancer therapy development
Daiichi Sankyo is aiming for at least ¥900 billion of revenue from its oncology business in the fiscal year ending in March 2026.
A health ministry panel has approved the messenger RNA vaccine Daichirona.
JAPAN / Science & Health
Aug 1, 2023
Japan panel endorses first domestically developed COVID vaccine
The shot is based on the original strain of the coronavirus, making it unlikely that it will be used in Japan or elsewhere.
Japan Times
BUSINESS / Companies
Jun 7, 2023
AstraZeneca’s Japan partner to go solo on future cancer drugs
Daiichi Sankyo is expanding its sales and development staff overseas, aiming to boost production capacity so that it can handle its cancer drugs business entirely on its own.
Japan Times
BUSINESS
Jan 13, 2023
Japan's Daiichi Sankyo applies for approval of mRNA COVID vaccine
An approval would give Japan a homegrown mRNA vaccine — a vaccine type that has played a dominant role in the country's COVID-19 inoculation drive to this point.
Japan Times
JAPAN / Science & Health
Nov 15, 2022
Japan's Daiichi Sankyo says mRNA COVID vaccine successful in booster trial
Approval would give Japan a home-grown source for mRNA vaccines, which have made up the bulk of its COVID-19 inoculations to date.
Japan Times
COMMENTARY / World
Jun 8, 2022
The drug that could transform breast cancer treatment
The early success of Enhertu, from AstraZeneca and Daiichi Sankyo, bodes well for an entire class of medicines that may one day replace conventional chemotherapy.
Japan Times
BUSINESS
Dec 27, 2021
Tardy COVID-19 vaccine makers under fire for trials in developing nations
Vaccine developers at the testing phase now are seeking developing countries where vaccination rates remain low and the virus is still active.
Japan Times
BUSINESS / Companies
Sep 6, 2021
Daiichi Sankyo positions its COVID-19 vaccine as a booster in Japan
Daiichi Sankyo is aiming for full regulatory approval by the second half of next year.
Japan Times
JAPAN / Science & Health
Mar 23, 2021
Japanese firms launch domestic clinical trials for COVID-19 vaccines
Even as Daiichi Sankyo and KM Biologics begin work to prove their shots' efficacy and safety, the public is unlikely to have access to them until fiscal 2022 at the earliest.
JAPAN / Science & Health
Aug 31, 2020
Daiichi Sankyo's COVID-19 vaccine candidate selected by Japanese drug discovery body
Daiichi Sankyo Co. said on Monday that its mRNA-based COVID-19 vaccine candidate was selected for inclusion in a drug discovery program by the Japan Agency for Medical Research and Development.
Japan Times
BUSINESS / Companies
Jul 28, 2020
Astra to pay Daiichi up to $6 billion for new cancer drug
AstraZeneca is forging ahead to become a global oncology powerhouse, even as it works on a vaccine for the coronavirus pandemic.
Japan Times
JAPAN / Science & Health
Jun 16, 2019
Drug devised to replace chemotherapy may reshape cancer care
A class of drugs is emerging that can attack cancer cells in the body without damaging surrounding healthy ones. They have the potential to replace chemotherapy and its disruptive side effects, reshaping the future of cancer care.
Japan Times
BUSINESS / Companies
Mar 29, 2019
AstraZeneca bets $6.9 billion that Daiichi Sankyo therapy will transform cancer treatment
Britain's AstraZeneca's biggest deal in recent memory give it access to the Japanese drugmaker's promising but difficult to pronounce cancer treatment: trastuzumab deruxtecan.
Japan Times
BUSINESS / Companies
Sep 29, 2017
Opioids demand rises in Japan as seniors use drugs to ease pain and improve quality of life
Selling painkillers in Japan used to be like pulling teeth. That was until baby boomers discovered how analgesics could take the sting from arthritis, diabetic nerve damage and the ravages of cancer.
Japan Times
BUSINESS / Companies
Aug 2, 2017
Daiichi Sankyo settles U.S. lawsuits over intestinal damage from blood-pressure drugs, paying $300 million
Daiichi Sankyo Inc. has settled thousands of lawsuits alleging its blood-pressure drugs caused intestinal damage, bringing to $339 million the amount the drugmaker has paid over the medicines.
Japan to revise consumption tax exemption for overseas tourists
Tourists walk through Nakamise shopping street near Sensoji Temple in Tokyo in April
Japan's tourism industry hit by cancellations after megaquake alert
A beach closed due to a megaquake alert in Hiratsuka, Kanagawa Prefecture, from Friday to Thursday.
Focus shifts to incoming typhoon as Tropical Storm Maria dissipates
Newly formed Tropical Storm Ampil, which is forecast to approach eastern Japan this weekend, is seen on the left side of this satellite image.
Kishida to step down in September in bid to show ‘LDP has changed’
Prime Minister Fumio Kishida speaks during a news conference Wednesday at the Prime Minister's Office in Tokyo.
Publisher finds surprise audience after translating history textbooks
Yamakawa Shuppansha president Takeshi Nozawa holds the publisher's textbook on Japanese history — used in high schools across Japan — alongside the new English version in Tokyo on May 23.
Economic security is about strengthening and sustaining growth, former minister says
Former economic security minister Takayuki Kobayashi says changes in the international balance of power, along with deepening economic interdependence, have led some countries to attempt to use their economic power to impose their will on others.
Ice bandanas, convenience store breaks: Running under Japan’s summer sun
Blistering heat is becoming a fixture of summer in Japan, but a few tweaks to your routine can make your outdoor runs bearable — if not enjoyable — until cooler temperatures return.
Japan issued its first-ever megaquake alert. What does that mean?
Naoshi Hirata (center), chairman of a committee tasked with evaluating the risk of a Nankai Trough earthquake, speaks at a news conference in Tokyo on Friday.
France brings down the curtain on its Olympic party with Tom Cruise and Leon Marchand
Fireworks are set off during the closing ceremony of the 2024 Paris Olympics at Stade de France in Saint-Denis on Sunday.
Japan fuels U.S. LNG boom even as climate targets and impacts loom
Flaring at the Cameron LNG export terminal in Hackberry, Louisiana. Flaring, a common sight at LNG plants, is a controlled burning of gas for reasons ranging from depressurizing equipment to disposing of gas that can’t be used. The practice is a "waste of money" and negatively impacts climate change and human health, says the International Energy Agency.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Sociologist Gracia Liu-Farrer argues that even though immigration doesn't figure into Japan's autobiography, it is more of a self-perception than a reality.
In search of the ‘Japanese dream’
By Thu-Huong Ha

SUSTAINABLE JAPAN

Azabudai Hills, Tokyo’s green new downtown ‘village’
Azabudai Hills, Tokyo’s green new downtown ‘village’

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER